Estimation of The Budget Saving Potential Due To The Introduction of Benepali®, An Etanercept Biosimilar, For The Treatment of All Licensed Adult Etanercept Indications In Spain
Nov 1, 2016, 00:00 AM
10.1016/j.jval.2016.09.1088
https://www.valueinhealthjournal.com/article/S1098-3015(16)32454-8/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1017
First Page :
A533
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32454-8&doi=10.1016/j.jval.2016.09.1088